Wave Historical Balance Sheet
WVE Stock | USD 15.10 0.11 0.73% |
Trend analysis of Wave Life Sciences balance sheet accounts such as Total Assets of 200.5 M, Short Long Term Debt Total of 20.4 M, Other Current Liabilities of 8.5 M or Total Current Liabilities of 195.8 M provides information on Wave Life's total assets, liabilities, and equity, which is the actual value of Wave Life Sciences to its prevalent stockholders. By breaking down trends over time using Wave Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Wave Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Wave Life Sciences is a good buy for the upcoming year.
Wave Life Inventory |
|
Wave |
About Wave Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Wave Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Wave Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Wave Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Wave currently owns. An asset can also be divided into two categories, current and non-current.
Wave Life Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Wave Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Wave Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Wave Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Wave Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Warrants
Securities that give the holder the right to purchase a company's stock at a specified price before a certain date. Warrants are similar to options but are typically issued directly by the company.Most accounts from Wave Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Wave Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At present, Wave Life's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 96.6 M, whereas Short and Long Term Debt Total is forecasted to decline to about 20.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 29.9M | 37.6M | 32.1M | 20.4M | Total Assets | 207.0M | 146.4M | 274.9M | 200.5M |
Wave Life balance sheet Correlations
Click cells to compare fundamentals
Wave Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Wave Life balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 284.3M | 279.2M | 207.0M | 146.4M | 274.9M | 200.5M | |
Short Long Term Debt Total | 32.5M | 29.3M | 29.9M | 37.6M | 32.1M | 20.4M | |
Other Current Liab | 16.2M | 8.3M | 9.9M | 12.1M | 10.1M | 8.5M | |
Total Current Liabilities | 118.2M | 121.0M | 64.2M | 71.5M | 186.4M | 195.8M | |
Total Stockholder Equity | 63.7M | 82.8M | 32.5M | (45.1M) | 47.5M | 49.3M | |
Other Liab | 65.2M | 42.0M | 77.5M | 80.0M | 92.0M | 96.6M | |
Property Plant And Equipment Net | 54.5M | 45.4M | 40.6M | 44.1M | 35.7M | 30.2M | |
Current Deferred Revenue | 89.7M | 91.6M | 37.1M | 31.6M | 150.1M | 157.6M | |
Net Debt | (114.6M) | (155.2M) | (120.6M) | (50.9M) | (168.2M) | (176.6M) | |
Retained Earnings | (533.4M) | (683.3M) | (805.5M) | (967.3M) | (1.0B) | (973.6M) | |
Accounts Payable | 9.1M | 13.8M | 7.3M | 16.9M | 12.8M | 8.9M | |
Cash | 147.2M | 184.5M | 150.6M | 88.5M | 200.4M | 140.1M | |
Non Current Assets Total | 98.8M | 49.2M | 44.4M | 47.8M | 39.6M | 42.5M | |
Other Assets | 44.3M | 3.8M | 3.8M | 3.7M | 4.3M | 4.1M | |
Cash And Short Term Investments | 147.2M | 184.5M | 150.6M | 88.5M | 200.4M | 140.1M | |
Net Receivables | 10M | 20M | 30M | 0.0 | 21.1M | 22.1M | |
Common Stock Total Equity | 539.5M | 694.1M | 749.9M | 802.8M | 923.3M | 969.4M | |
Common Stock Shares Outstanding | 33.9M | 39.2M | 51.8M | 78.9M | 106.1M | 111.4M | |
Liabilities And Stockholders Equity | 284.3M | 279.2M | 207.0M | 146.4M | 274.9M | 200.5M | |
Non Current Liabilities Total | 102.4M | 75.4M | 110.3M | 120.0M | 41.0M | 59.0M | |
Other Current Assets | 8.7M | 15.5M | 12M | 10.0M | 13.9M | 8.7M | |
Total Liab | 220.5M | 196.5M | 174.5M | 191.5M | 227.4M | 132.8M | |
Property Plant And Equipment Gross | 54.5M | 45.4M | 40.6M | 44.1M | 78.4M | 82.4M | |
Total Current Assets | 185.5M | 230.0M | 162.6M | 98.5M | 235.4M | 158.0M | |
Accumulated Other Comprehensive Income | 267K | 389K | 181K | (29K) | (124K) | (117.8K) | |
Short Term Debt | 3.2M | 7.4M | 9.9M | 11.0M | 13.4M | 14.1M | |
Common Stock | 539.5M | 694.1M | 749.9M | 802.8M | 935.4M | 481.8M | |
Property Plant Equipment | 54.5M | 29.2M | 22.3M | 17.3M | 19.9M | 22.5M | |
Net Tangible Assets | 63.7M | 90.7M | 40.4M | (37.2M) | (33.5M) | (31.8M) | |
Other Stockholder Equity | 49.4M | 63.7M | 80.1M | 111.6M | 129.2M | 135.7M | |
Non Currrent Assets Other | 10.7M | 115K | 148K | 62K | 3.9M | 6.9M | |
Capital Surpluse | 57.3M | 71.6M | 88.0M | 119.4M | 137.4M | 144.2M | |
Capital Lease Obligations | 32.5M | 29.3M | 29.9M | 37.6M | 32.1M | 21.5M | |
Non Current Liabilities Other | 1.7M | 67.5M | 102.4M | 112.1M | 128.9M | 135.3M | |
Net Invested Capital | 63.7M | 82.8M | 32.5M | (45.1M) | 39.6M | 44.2M | |
Net Working Capital | 67.3M | 109.0M | 98.4M | 27.0M | 48.9M | 63.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.11) | Return On Assets (0.34) | Return On Equity (2.44) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.